nephrotic syndrome in children


Cite item

Full Text

Abstract

Approaches to optimization of diagnosing and treatment of nephrotic syndrome in children is discussed

About the authors

- -

References

  1. Clark AG., Barratt TM. Steroid-responsive nephrotic syndrome. In: Barratt TM, Avner ED, Harmon WE(eds) Pediatr Nephrology, 4th ed. Lippincott, Williams and Wilkins, Baltimore,1999:731-747.
  2. Серов В.В., Варшавский В.А. Что называть гломерулонефритом? Спорные вопросы классификации. Архив патологии, 1987, вып 1, 67-82.
  3. Broyer M., Meyrier A., Niaudet P, Habib R. Мinimal changes and focal segmental glomerular sclerosis. Oxford textbook of clinical nephrology, 2-nd ed. A.Davison, S.Cameron, J-P Grunftld et al., Oxford, New-York, Tokio: Oxford medical press. 1998, p.493-523.
  4. Матвеев М.П. Нефротический синдром у детей. Учебное телевидение, М. 1975, 25 с.
  5. Игнатова М.С., Вельтищев Ю.Е. Детская нефрология. Руководство для врачей. Л.: Медицина. 1989, 455с.
  6. Jalanko H. Pathogenesis of proteinuria: lessons learned from nephrin and podocin. Pediatr Nephrol 2003, 18: 487-491.
  7. Kaplan JM., Kim SH, North KN.et al .Mutation in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nature Genet , 2000, 24: 251-256.
  8. Kestila M., Lenkkeri U., Mannikko M. et al. Positionally cloned gene for a noval glomerular protein - nephrin- is mutated in congenital nephrotic syndrome. Mol Cell 1998;1: 575-582.
  9. Furchshuber A., Niaudet P., Gribouval O. et al. Congenital nephrotic syndrome of the Finnish type: linkage to the locus in a non-Finnish population. Pediatr Nephrol,1996, 10:135-138.
  10. Fuchshuber A., Jean G., Gribouval O et al. Mapping a gene (SNR1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet, 1995, 4: 2155-2158.
  11. Weber S, Gribouval O, Esquivel E, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004; 66(2): 571-579.
  12. Приходина Л.С., Полтавец Н.В., Заклязьминская Е.В., и др.. Скрининг мутаций в гене подоцина (NPHS2) у детей со спорадическим стероид-резистентным нефротическим синдромом. Нефрология и диализ, 2007; Т.9 №4, 434-438.
  13. Игнатова М.С. Шатохина О.В. Диагностика и лечение нефротического синдрома у детей. 2009. М.МИА, 287с.
  14. Москалева Е.С. Клинико-патогенетическая характеристика нефротического синдрома у детей с атопическими проявлениями. Автореферат дисс…. К.м.н.,1989, М.,26стр.
  15. Длин В.В., Асратян А.А., Рейзис А.Р. и др. Частота маркеров НВ-вирусной инфекции у больных с нефротическим синдромом. Педиатрия,1991, № 7, 24-27.
  16. Durkan A, Hodson E, Willis N, Craig J. Non-corticosteroid treatment for nephrotic syndrome in children (Cochrane Review). (2003) The Cochrane Library. 1. Oxford, Update Software Ltd.
  17. Latta K, von Schnakenburg C, Ehrich JH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001; 16:271-282
  18. Папиж С.А., Фокеева Е.В., Ружицкая Е.А. и др. Применение иммуномодулирующего препарата левамизола в лечении гормонозависимого и часторецидивирующего нефротического синдрома при первичном гломерулонефрите у детей. Нефрология и диализ. 2004, т.6. №1, 58-61.
  19. Borel JF. Mechanism of action of cyclosporine A & rationale for use in nephrotic syndrome. Clin Nephrol. 1991, v.5.p.23-30.
  20. Игнатова М.С., Харина Е.А., Курбанова Э.Г. и др. Эффективность Сандиммун-Неорала при нефротическом синдроме у детей России и Казахстана, по данным многоцентрового контролируемого исследования. Педиатрия, 2001, №6, с.90-94
  21. Meyrier A., Noel LH, Auriche P, Callard P. Long-term renal tolerance of cyclosporine treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994;45:1446-1456.
  22. Eugui E.M., Amquist S.J., Muller C.D., Allison A.C. Lymphocytoselective citostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol. 1991; 33:161-173.
  23. Fujihara CK, Avancini Costa Malheiros DM, de Lourdes Noronha I. et al. Mycophenolate mofetil reduces renal injury in the chronic nitric oxide synthase inhibition model. Hypertension 2001; 37 (1): 170-175.
  24. Bagga A, Hari P., Moudgil A., Jordan S.C. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidneу Disease 2003:42;6,1114-1120
  25. Hogg R, Fitzibbons L, Bruik J et al. Multicenter trial of mycophenolate mofetil (MMF) in children with steroid dependent (SD) or frequent relapsing (FR) nephrotic syndrome (NS). Report of the South West Pediatric Nephrology Study Group. Nephrol Dial Transplant. 2003; 18: 261.
  26. Dorresteijn EM, Holthe JEK, Levtchenko EN, Nauta J. et al. Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 2008;23:2013-2020.
  27. Massella L., Belingheri M, Ghio L, Edefonti A. et al. Tacrolimus (TAC) in pediatric multidrug-resistant (MDRNS) and steroid-dependent nephrotic syndrome: a multicentre experience. Pediatr Nephrol 2008;23:1623, P105.
  28. Bhimma R, Adhikari M, Asharam K, Connolly C. Management of Steroid-Resistant Focal Segmental Glomerulosclerosis in Children Using Tacrolimus. Am J Nephrol 2006 26(6):544-551.
  29. BrochardK., Guigonis V, Lecirec-Sellier AL, et al. Long term effect of Rituximab treatment in severe steroid dependent nephrotic syndrome. Pediatr Nephrol 2008; 23:1592, O40.
  30. Elhence R, Gulati S, Kher V, et al. Intravenous pulse cyclophospamide - a new regime for steroid-resistant minimal change nephrotic syndrome. Pediatr Nephrol 1994;8:1-3.
  31. Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN. Intravenous cyclophosphamide in steroid resistant nephrotic syndrome. Pediatr Nephrol 2003; 18:351-356.
  32. Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W; Arbeitsgemeinschaft fur Padiatrische Nephrologie Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome - a randomized controlled multicentre trial by the Arbeitsgemeinschaft fur Padiatrische Nephrologie. Pediatr Nephrol 2008;23:1483-1493.
  33. Игнатова М.С.,Коровина Н.А. Диагностика и лечение нефропатий у детей. М. ГЭОТАР-МЕДИА., 2007, 332с.
  34. Habashy D, Hodson E.M., Craig J.C. Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol 2003; 18:906-912
  35. Waldo F.B., Benfield M.R., Kohaut E.C. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A and prednisone. Pediatr Nephrol 1998; 12: 397-400..
  36. Ehrich J.H.H., Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 2007; 22:2183-2193.
  37. Mendoza S.A., Reznik V.M., Griswold W.R. et al. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 1990; 4: 303-307.
  38. Lee JS, Shin JL, Kim JA, Leong IC, et al. The effect of long-term methylprednisolone pulse therapy by the Tune-Mendoza protocol without cytotoxics on of steroid-resistant focal segmental glomerulosclerosis in children. Pediatr Nephrol 2008;23:1636, P157
  39. Montane B, Abitbol C, Chandar J, Strauss J, Zilleruello G. Combination mycophenolate and angiotensin blockade in the treatment of steroid resistant nephrotic syndrome. Pediatr Nephrol 2001; 16: C120.
  40. Приходина Л.С, Длин В.В., Турпитко О.Ю., и др. Первый опыт использования мофетила микофенолата в лечении гломерулонефрита у детей. Нефрология и диализ. 2006; 1: 55-59
  41. Ulinski T, Ranchin B, Said M-H, et al. Switch from cyclosporine A (CyA) to mycophenolate mofetil improves kidney function in children with nephrotic syndrome and CyA-induced nephrotoxicity. Nephrol Dial Transplant 2003);18 (Suppl 4): 261
  42. М.С.Игнатова ред. Детская нефрология. Руководство для врачей. 3 изд дополненное и переработанное. -. М.МИА. 2011, 692с.
  43. Приходина Л.С., Турпитко О.Ю., Длин В.В., Игнатова М.С. Использование такролимуса у детей со стероид-резистентным нефротическим синдромом. Нефрология и диализ, 2010
  44. Bagga A, Sinha A, Moudgil A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 2007;356:2751-2752.
  45. Ponticelli C, Zuccheli P, Passerin IP,Cesena P. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 1992; 327: 599-603.
  46. Cho ME, Hurley JK, Kopp JB. Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity. Am J Kidney Dis. 2007;49(2):310-317.
  47. Bagga A, Mudigoudar BD, Hari P, Vasudev V. Enalapril dosage in steroid-resistant nephrotic syndrome. Pediatr Nephrol 2004;19:45-50.
  48. Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998; 32:72-79.
  49. Weber S, Gribouval O, Esquivel E, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004; 66(2): 571-579.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies